15d-PGJ2 inhibits the expression of TGF-β-induced connective tissue growth factor by inhibiting Smad2 phosphorylation, which is independent of PPAR; 15d-PGJ2 might also act through a PPAR-dependent mechanism in human hepatoma cells. This evidence concerns the gene PPARA and hepatocellular carcinoma.